Serum Ghrelin Levels and the Effects of Antidepressants in Major Depressive Disorder and Panic Disorder

Publisher： Karger

E-ISSN： 1423-0224|66|3|185-192

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.66, Iss.3, 2012-08, pp. : 185-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Serum Cytokine Levels on EEG-Measured Arousal Regulation in Patients with Major Depressive Disorder and Healthy Controls

Neuropsychobiology, Vol. 73, Iss. 1, 2016-01 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Pain Thresholds as a Putative Functional Test for Cerebral Laterality in Major Depressive Disorder and Panic Disorder¹

Neuropsychobiology, Vol. 48, Iss. 3, 2003-11 ,pp. : 146-151

Karger

Access to resources Recommend Favorite

Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines

Neuropsychobiology, Vol. 63, Iss. 1, 2010-10 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Antioxidant Enzyme and Malondialdehyde Levels in Patients with Panic Disorder

Neuropsychobiology, Vol. 46, Iss. 4, 2003-02 ,pp. : 186-189

Karger

Access to resources Recommend Favorite

Levels of Monocyte Reactive Oxygen Species Are Associated with Reduced Natural Killer Cell Activity in Major Depressive Disorder

Neuropsychobiology, Vol. 44, Iss. 1, 2001-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite